Skip to main content

Table 5 Related examination indicators after treatment

From: Influence of strengthened hemoperfusion combined with continuous venovenous hemofiltration on prognosis of patients with acute paraquat poisoning: SHP + CVVH improve prognosis of acute PQ patients

Indexes Control
(n = 98)
HP
(n = 67)
CVVH
(n = 59)
SHP
(n = 135)
SHP + CVVH
(n = 128)
P
Maximum BUN (mmol/L) 49.96 ± 22.8 37.03 ± 18.3a 45.04 ± 23.90 27.13 ± 14.58abc 13.44 ± 12.05abcd <0.001
Maximum CREA (μmol/L) 749.01 ± 291.02 411.22 ± 174.40a 504.77 ± 183.30a 241.11 ± 108.23abc 174.26 ± 91.74bcd <0.001
Maximum AST (IU/L) 88.71 ± 76.63 90.04 ± 70.35 92.05 ± 70.88 84.08 ± 75.54a 87.03 ± 65.45abcd 0.018
Maximum ALT (IU/L) 104.43 ± 62.20 101.99 ± 63.47 103.24 ± 66.41 95.07 ± 73.30 91.47 ± 71.12 <0.001
Arterial blood gas analysis
 Minimum PH (mmHg) 7.24 ± 0.11 7.21 ± 0.16 7.26 ± 0.13b 7.29 ± 0.10b 7.28 ± 0.13 <0.001
 Minimum PO2 (mmHg) 34.17 ± 24.07 52.22 ± 26.79a 41.03 ± 17.79b 63.71 ± 28.84 ac 72.20 ± 13.49abcd <0.001
 Maximum PCO2 (mmHg) 46.43 ± 14.05 47.02 ± 13.99 47.10 ± 13.01 45.07 ± 12.14abc 46.82 ± 11.94abc <0.001
  1. a: compared with the control group, P<0.05;
  2. b: compared with the HP group, P<0.05;
  3. c: compared with the HP group, P<0.05;
  4. d: compared with the CVVH group, P<0.05